These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25001652)

  • 1. If you have an active vagus nerve, cancer stage may no longer be important.
    Gidron Y; De Couck M; De Greve J
    J Biol Regul Homeost Agents; 2014; 28(2):195-201. PubMed ID: 25001652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients.
    De Couck M; van Brummelen D; Schallier D; De Grève J; Gidron Y
    Oncol Rep; 2013 Nov; 30(5):2435-41. PubMed ID: 24026706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norms of vagal nerve activity, indexed by Heart Rate Variability, in cancer patients.
    De Couck M; Gidron Y
    Cancer Epidemiol; 2013 Oct; 37(5):737-41. PubMed ID: 23725879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer.
    Mouton C; Ronson A; Razavi D; Delhaye F; Kupper N; Paesmans M; Moreau M; Nogaret JM; Hendlisz A; Gidron Y
    Auton Neurosci; 2012 Jan; 166(1-2):96-9. PubMed ID: 22070982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
    Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
    J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T; Dienemann H; Ebert W
    Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagal nerve activity predicts overall survival in metastatic pancreatic cancer, mediated by inflammation.
    De Couck M; Maréchal R; Moorthamers S; Van Laethem JL; Gidron Y
    Cancer Epidemiol; 2016 Feb; 40():47-51. PubMed ID: 26618335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer--T, N, or M?
    Zagars GK; Kavadi VS; Pollack A; von Eschenbach AC; Sands ME
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):21-32. PubMed ID: 7536722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
    Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y
    BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
    Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
    Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer.
    Japink D; Leers MP; Sosef MN; Nap M
    Anticancer Res; 2009 Aug; 29(8):3245-51. PubMed ID: 19661342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
    Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG
    Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile of prostate-specific antigen messenger RNA assessed by in situ hybridization is a novel prognostic marker for patients with untreated prostate cancer.
    Tsurusaki T; Koji T; Sakai H; Kanetake H; Saito Y
    Clin Cancer Res; 1998 Sep; 4(9):2187-94. PubMed ID: 9748138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
    Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
    Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.